Tenet Healthcare Corp (THC) SEC Filing 10-Q Quarterly report for the period ending Friday, June 30, 2017

Earnings Press Release
10-Q Quarterly Report
10-Q QoQ Changes
Tenet Healthcare Corp
Ticker: THC CIK: 70318

Exhibit 99.1

Tenet Reports Results for the Second Quarter Ended June 30, 2017


•	Reported a net loss from continuing operations attributable to Tenet shareholders of $56 million or $0.56 per diluted share. Adjusted diluted earnings per share from continuing operations was a loss of $0.17.


•	Adjusted EBITDA was $570 million, which included $23 million of gains primarily from the sale of home health and hospice assets.


•	Same-hospital patient revenue increased 0.4% and reflects a 1.9% increase in revenue per adjusted admission offset by a 1.4% decline in adjusted admissions. Hospital segment Adjusted EBITDA totaled $346 million.


•	Ambulatory Care segment revenue increased 3.8% on a same-facility system-wide basis, with cases decreasing 0.5% and revenue per case increasing 4.3%. Adjusted EBITDA for the Ambulatory segment was $164 million, an 18.0% increase, representing a margin of 34.7%.


•	Revenue from Conifer Health Solutions increased 3.6% with revenue from third parties increasing 9.4%. Conifer generated $60 million of Adjusted EBITDA, a 4.8% decrease, representing a margin of 15.0%.


•	Net cash provided by operating activities in the first half of 2017 was $401 million, a $181 million decline when compared to $582 million in the first half of 2016. Adjusted Free Cash Flow was $117 million in the first half of 2017, a $151 million decline when compared to $268 million in the first half of 2016.

•

Updated 2017 Outlook to reflect a range of factors, including the divestiture of the Company’s hospital operations in Houston, which closed on July 31, 2017. The updated Outlook for 2017 includes net income from continuing operations attributable to Tenet common shareholders of a loss of $115 million to a loss of $90 million, Adjusted EBITDA of $2.450 billion to $2.550 billion, a diluted loss per share from continuing operations of $1.14 to a loss of $0.89 and Adjusted diluted earnings per share from continuing operations of $0.69 to $0.99.

DALLAS - August 7, 2017 - Tenet Healthcare Corporation (NYSE:THC) reported a net loss from continuing operations attributable to Tenet shareholders of $56 million in the second quarter of 2017 compared to a $44 million net loss from continuing operations in the second quarter of 2016. Adjusted EBITDA was $570 million in the second quarter of 2017 compared to $629 million in the second quarter of 2016.

“While we experienced a softer volume environment in the second quarter, our teams responded well with solid performance on cost control, which mitigated the impact on our results,” said Trevor

The following information was filed by Tenet Healthcare Corp (THC) on Monday, August 7, 2017 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Tenet Healthcare Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Tenet Healthcare Corp.

Continue

Please wait while we load the requested 10-Q report or click the link below:

https://last10k.com/sec-filings/report/70318/000007031817000012/thc-20170630x10xq.htm